Belarus Pharmaceuticals and Healthcare Report Q4 2015

Date: September 23, 2015
Pages: 84
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: Download
ID: B0BEE68FA17EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Belarus continues to present limited opportunities for drugmakers owing to the heightened economic risk in the country. Regional security risks, namely between Russia and the west, poor governance and heavy state presence in the economy will present considerable barriers to foreign interest.

Headline Expenditure Projections
  • Pharmaceuticals: BYR10,405bn in 2014 (USD1.02bn) to BYR12,769bn (USD863mn) in 2015; +22.7% in local currency terms and -15.0% in US dollar terms.
  • Healthcare: BYR48,816bn (USD4.76bn) in 2014 to BYR62,047bn (USD4.19bn) in 2015; +27.1% in local currency terms and -12.0% in US dollar terms.
BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2011-2019)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2011-2019)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2011-2019)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2011-2019)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Belarus 2013-2019)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
  Table: GDP Contribution To Growth (Belarus 2012-2020)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index - Q4 2015
Belarus Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Provision
Healthcare Sector Reforms
Healthcare Insurance
  Table: Healthcare Resources (Belarus 2009-2014)
  Table: Healthcare Personnel (Belarus 2009-2014)
  Table: Healthcare Activity (Belarus 2009-2014)
Medical Tourism
Research And Development
Clinical Trials
Regulatory Development
Recent Regulatory Developments
Customs Union
Pharmaceutical Advertising
Intellectual Property Rights
Counterfeit Drugs
Pricing And Reimbursement
Recent Pricing & Reimbursement Developments
Tendering Procedures
Competitive Landscape
Pharmaceutical Sector
Generic Drugmakers
Research-Based Industry
Recent Pharmaceutical Sector Developments
Pharmaceutical Wholesale And Retail
Company Profile
Lekpharm
Demographic Forecast
Demographic Outlook
  Table: Population Headline Indicators (Belarus 1990-2025)
  Table: Key Population Ratios (Belarus 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Belarus 1990-2025)
  Table: Population By Age Group (Belarus 1990-2025)
  Table: Population By Age Group % (Belarus 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Belarus Pharmaceuticals and Healthcare Report Q2 2015 US$ 1,295.00 Mar, 2015 · 88 pages
Belarus Pharmaceuticals and Healthcare Report Q3 2015 US$ 1,295.00 Jun, 2015 · 86 pages
Thailand Pharmaceuticals and Healthcare Report Q2 2015 US$ 1,295.00 Jan, 2015 · 116 pages
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 US$ 1,295.00 Mar, 2015 · 82 pages

Ask Your Question

Belarus Pharmaceuticals and Healthcare Report Q4 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: